Get the Stockscreener App
10.74
0.14%
0.015
Drugs Made In America Acquisition Corp stock is traded at $10.74, with a volume of 28,108.
It is up +0.14% in the last 24 hours and up +0.37% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.72
Open:
$10.73
24h Volume:
28,108
Relative Volume:
0.80
Market Cap:
$260.49M
Revenue:
-
Net Income/Loss:
$6.66M
P/E Ratio:
54.19
EPS:
0.1982
Net Cash Flow:
$-379.20K
1W Performance:
+0.28%
1M Performance:
+0.37%
6M Performance:
+2.78%
1Y Performance:
+4.58%
1-Day Range:
$10.73
$10.73
1-Week Range:
$10.70
$10.73
52-Week Range:
$10.22
$10.73
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs XXI, LION, UMAC, CCXI, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.73 | 260.25M | 0 | 6.66M | -379.20K | 0.1982 |
XXI
Twenty One Capital Inc
|
6.245 | 3.12B | 0 | 4.35M | 456.40K | 0.3397 |
LION
Lionsgate Studios Corp
|
11.61 | 3.45B | 2.63B | -175.60M | 11.40M | -0.7173 |
UMAC
Unusual Machines Inc
|
27.00 | 1.41B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
14.10 | 813.22M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.14 | 644.64M | 0 | 8.58M | -1.11M | 0.134 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - Vinanet
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - Vinanet
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - Vinanet
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsDouble Top - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet
Pfizer Inc. - Encyclopedia Britannica
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - Vinanet
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSynthetic Short - Vinanet
Law firm launches legal inquiries into mergers of LXP, DMAA, PSNL, and FNWD for shareholder protection. - Pluang
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.040 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - tradingkey.com
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Flat at $10.16 Amid Low VolatilityRisk Reward Setups - Vinanet
BLZR|Trailblazer Acquisition Corp|Price:10.160| - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
TradingKey - TradingKey
LATA|Galata Acquisition Corp II|Price:10.150|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):